In this study, we explored the impact of CHRDL2 overexpression on CRC cells to investigate whether CHRDL2's inhibition of BMP signalling intensifies WNT signalling and enhances the cancer stem‐cell phenotype and response to treatment. The gene discussed is CHRDL2; the disease is cancer.